文献
J-GLOBAL ID:201702261959619971
整理番号:17A1505441
lncRNA LINC00152ノックダウンはEGFR/PI3K/AKT経路を介して肺癌の生物学的活性を抑制する効果を有する【Powered by NICT】
lncRNA LINC00152 knockdown had effects to suppress biological activity of lung cancer via EGFR/PI3K/AKT pathway
著者 (7件):
Zhang Yan
(Tumor Four Departments, People’s Hospital of Hebei Medical University, People’s Republic of China)
,
Xiang Cheng
(Tumor Four Departments, People’s Hospital of Hebei Medical University, People’s Republic of China)
,
Wang Yuling
(Respiratory Oncology, Shijiazhuang City, The Fifth Hospital, People’s Republic of China)
,
Duan Yuanyuan
(Hebei Medical University, Graduate School, People’s Republic of China)
,
Liu Ci
(Tumor Four Departments, People’s Hospital of Hebei Medical University, People’s Republic of China)
,
Jin Yongli
(Tumor Four Departments, People’s Hospital of Hebei Medical University, People’s Republic of China)
,
Zhang Yajing
(Tumor Four Departments, People’s Hospital of Hebei Medical University, People’s Republic of China)
資料名:
Biomedicine & Pharmacotherapy
(Biomedicine & Pharmacotherapy)
巻:
94
ページ:
644-651
発行年:
2017年
JST資料番号:
A0845C
ISSN:
0753-3322
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)